Cargando…
HPV genoprevalence and HPV knowledge in young women in Mongolia, five years following a pilot 4vHPV vaccination campaign
BACKGROUND: In a 2012 pilot, 9111 Mongolian girls aged 11–17 years received three doses of the quadrivalent (4vHPV) vaccine, Gardasil(®). This is the first study to measure early vaccine effectiveness and assess knowledge and attitudes of young women in Mongolia in relation to the human papillomavir...
Autores principales: | Batmunkh, Tsetsegsaikhan, von Mollendorf, Claire, Tulgaa, Khosbayar, Surenjav, Unursaikhan, Dalmau, Marguerite T., Namjil, Narantuya, Tsedevdamba, Battsetseg, Tsegmed, Sambuu, Enkhmaa, Jalserd, Garland, Suzanne M., Mulholland, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658929/ https://www.ncbi.nlm.nih.gov/pubmed/31276802 http://dx.doi.org/10.1016/j.pvr.2019.100175 |
Ejemplares similares
-
A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination
por: Batmunkh, Tsetsegsaihan, et al.
Publicado: (2020) -
Cervical Cancer Prevention Through HPV Vaccination in Low- and Middle-Income Countries in Asia
por: Toh, Zheng Quan, et al.
Publicado: (2017) -
A call for switching to a 1-dose 9vHPV national vaccination program in Ethiopia
por: Gelanew, Tesfaye, et al.
Publicado: (2023) -
Incidence of Stomach and Esophageal Cancers in Mongolia: Data from 2009 to 2018
por: Lonjid, Tulgaa, et al.
Publicado: (2020) -
Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda
por: Kumakech, Edward, et al.
Publicado: (2016)